MIM
QTTB icon

Monashee Investment Management’s Q32 Bio QTTB Stock Holding History

Monashee Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,500
Closed -$842K – 209
2018
Q1 		$842K Buy
+2,500
New +$841K 0.23% 81

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Monashee Investment Management's QTTB Position: Q2 2018 in Review

Monashee Investment Management sold out of Q32 Bio (QTTB) in Q2 2018, closing a stake of 2,500 shares — an estimated $842K sold.

Monashee Investment Management first reported a position in QTTB in Q1 2018 and held it in 1 quarter. The position peaked at $842K in Q1 2018. 53 funds tracked by Wall St. Rank hold QTTB as of Q2 2018.

  • Monashee Investment Management reported no remaining Q32 Bio position as of Q2 2018 after selling out during the quarter.
  • Monashee Investment Management sold 2,500 Q32 Bio shares in Q2 2018, an estimated $842K.
  • Monashee Investment Management first reported a position in Q32 Bio in Q1 2018 and held it in 1 quarter.
  • Monashee Investment Management's Q32 Bio position peaked at $842K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2018.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.